| 2026-02-24 |
详情>>
业绩披露：
2025年年报每股收益19.79墨西哥比索,归母净利润100.01亿墨西哥比索,同比去年增长16.12%
|
| 2026-02-23 |
财报披露：
美东时间 2026-02-23 盘后发布财报
|
| 2025-10-21 |
详情>>
业绩披露：
2025年三季报(累计)每股收益16.25墨西哥比索,归母净利润82.09亿墨西哥比索,同比去年增长22.41%
|
| 2025-07-22 |
详情>>
业绩披露：
2025年中报每股收益10.91墨西哥比索,归母净利润55.13亿墨西哥比索,同比去年增长16.72%
|
| 2025-04-29 |
详情>>
业绩披露：
2025年一季报每股收益5.66墨西哥比索,归母净利润28.58亿墨西哥比索,同比去年增长15.68%
|
| 2025-04-24 |
详情>>
业绩披露：
2024年年报每股收益17.04墨西哥比索,归母净利润86.12亿墨西哥比索,同比去年增长-9.75%
|
| 2025-04-24 |
详情>>
业绩披露：
2022年年报每股收益17.73墨西哥比索,归母净利润90.13亿墨西哥比索,同比去年增长50.28%
|
| 2024-10-22 |
详情>>
业绩披露：
2024年三季报(累计)每股收益13.27墨西哥比索,归母净利润67.06亿墨西哥比索,同比去年增长-9.77%
|
| 2024-07-23 |
详情>>
业绩披露：
2024年中报每股收益9.35墨西哥比索,归母净利润47.23亿墨西哥比索,同比去年增长-6.53%
|
| 2024-04-29 |
详情>>
股本变动：
变动后总股本5052.77万股
变动原因 ▼▲
- 原因：
- From January 1, 2023 to December 31, 2023
Cancellation of repurchase of shares
|
| 2024-04-29 |
详情>>
业绩披露：
2023年年报每股收益18.89墨西哥比索,归母净利润95.43亿墨西哥比索,同比去年增长5.88%
|
| 2024-04-23 |
详情>>
业绩披露：
2024年一季报每股收益4.89墨西哥比索,归母净利润24.71亿墨西哥比索,同比去年增长-3.68%
|
| 2024-02-29 |
股东大会：
将于2024-04-25召开股东大会
会议内容 ▼▲
- 1.Proposal to reduce the Company’s shareholders’ equity by Ps. 13.86 (THIRTEEN PESOS 86/100 M.N.) per share outstanding and to be paid within the 12 (TWELVE) months following its approval, and, as a consequence of this reduction, the necessary amendment to Article Six of the Company’s by-laws.
2.Make all the legal and corporate changes, and amendment to Article Six of the Company’s by-laws, as a result of the approvals of this Shareholders’ Meeting.
3.Appointment and designation of special delegates to appear before a notary public and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2024-02-29 |
股东大会：
将于2024-04-25召开股东大会
会议内容 ▼▲
- I.In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:
a.The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2023, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in accordance with Mexican Financial Reporting Standards (“MFRS”), as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards (“IFRS”), each based on the Company’s most recent financial statements under both standards, as well as the 2023 Sustainability Report.
b.Board of directors’ opinion to the Chief Executive Officer’s report.
c.Board of directors’ report in accordance with Article 172, clause b, of the Mexican General Corporations Law, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
d.Report on transactions and activities undertaken by the Company’s board of directors during the fiscal year ended December 31, 2023, pursuant to the Mexican Securities Market Law.
e.The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law, as well as the ratification of the actions of the various committees, and release from further obligations.
f.Report on the Company’s compliance with tax obligations for the fiscal year from January 1 to December 31, 2022, and an instruction to Company officials to comply with tax obligations corresponding to the fiscal year from January 1 and ended December 31, 2023, in accordance with Article 26, Section III of the Mexican Fiscal Code.
II.As a result of the reports in item I above, ratification of the actions of our board of directors and officers and release from further obligations in the fulfillment of their duties.
III.Presentation, discussion, and submission for approval of the Company’s financial statements for the fiscal year from January 1 to December 31, 2023, on an unconsolidated basis, in accordance with MFRS for purposes of calculating legal reserves, net income, fiscal effects related to dividend payments and capital reduction, as applicable. The financial statements of the Company and its subsidiaries on a consolidated basis in accordance with IFRS for their publication to financial markets, with respect to our operations that took place during the fiscal year from January 1 to December 31, 2023, and approval of the external auditor’s report regarding both aforementioned financial statements.
IV.Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2023, reported in its unconsolidated financial statements, presented in agenda item III above and audited in accordance with MFRS, the allocation of 5% (FIVE PERCENT) towards increasing the Company’s legal reserves, in accordance with Article 20 of the Mexican General Law of Commercial Corporations, with the remaining balance to be allocated to the account for net income pending allocation.
V.Cancellation of any amounts outstanding under the share repurchase program approved at the Annual General Ordinary Shareholders’ Meeting that took place on April 13, 2023, which amounts to Ps. 2,500,000,000.00 (TWO BILLION FIVE HUNDRED MILLION PESOS 00/100 M.N.). In addition to the approval of Ps. 2,500,000,000.00 (TWO BILLION FIVE HUNDRED MILLION PESOS 00/100 M.N.) as the maximum amount to be allocated towards the repurchase of the Company’s shares or credit instruments that represent such shares for the 12-month period following April 25, 2024, in accordance with Article 56, Section IV of the Mexican Securities Market Law.
VI.The report regarding the designation or ratification of the four members of the board of directors and their respective alternates named by the Series BB shareholders.
VII.Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by any holder or group of holders of Series B shares that owns, individually or collectively, 10% or more of the Company’s common stock.
VIII.Ratification and/or designation of the persons that will serve as members of the Company’s board of directors, as designated by the Series B shareholders and certification of independence.
IX.Ratification and/or designation of the Chairman of the Company’s board of directors, in accordance with Article 16 of the Company’s by-laws.
X.Ratification of the compensation paid to the members of the Company’s board of directors during the 2023 fiscal year and determination of the compensation to be paid in 2024.
XI.Ratification and/or designation of the member of our board of directors designated by the Series B shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s bylaws.
XII.Ratification and/or designation of the President of the Audit and Corporate Practices Committee.
XIII.The report concerning compliance with Article 29 of the Company’s bylaws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.
XIV.Appointment and designation of special delegates to appear before a notary public and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2023-04-19 |
股东大会：
将于2023-05-22召开股东大会
会议内容 ▼▲
- 1.The report regarding the designation or ratification of the four members of the Board of Directors and their respective alternates appointed by the Series BB shareholders.
2.Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by the Series B shareholders.
3.Ratification and/or designation of the member of our Board of Directors designated by the Series B shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s bylaws.
4.Appointment and designation of special delegates to appear before a public notary and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2023-03-02 |
股东大会：
将于2023-04-13召开股东大会
会议内容 ▼▲
- 1.In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:
a.The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2022, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in accordance with Mexican Financial Reporting Standards (“MFRS”), as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards (“IFRS”), each based on the Company’s most recent financial statements for the fiscal year ended December 31, 2022, under both standards, as well as the 2022 Sustainability Report.
b.Board of Directors’ opinion of the Chief Executive Officer’s report.
c.Board of Directors’ report in accordance with Article 172, clause b, of the Mexican General Law of Commercial Corporations, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
d.Report on transactions and activities undertaken by the Company’s Board of Directors during the fiscal year ended December 31, 2022, pursuant to the Mexican Securities Market Law.
e.The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law, as well as the ratification of the actions of the various committees, and release from further obligations.
f.Report on the Company’s compliance with tax obligations for the fiscal year from January 1 to December 31, 2021, and an instruction to Company officers to comply with tax obligations corresponding to the fiscal year from January 1 and ended December 31, 2022, in accordance with Article 26, Section III of the Mexican Fiscal Code.
2.As a result of the reports in item I above, ratification of the actions of our Board of Directors and officers and release from further obligations in the fulfillment of their duties.
3.Presentation, discussion, and submission for approval of the Company’s financial statements for the fiscal year from January 1 to December 31, 2022, on an unconsolidated basis, in accordance with MFRS for purposes of calculating legal reserves, net income, fiscal effects related to dividend payments and capital reduction, as applicable, and approval of the financial statements of the Company and its subsidiaries on a consolidated basis in accordance with IFRS for their publication to financial markets, with respect to our operations that took place during the fiscal year from January 1 to December 31, 2022; and approval of the external auditor’s report regarding both aforementioned financial statements.
4.Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2022, reported in its unconsolidated financial statements, presented in agenda item III above and audited in accordance with MFRS, which was Ps. 8,882,181,314.00 (EIGHT BILLION EIGHT HUNDRED EIGHTY-TWO MILLION ONE HUNDRED EIGHTY-ONE THOUSAND THREE HUNDRED FOURTEEN PESOS 00/100 M.N.), the allocation of Ps. 444,109,066.00 (FOUR HUNDRED FORTY-FOUR MILLION ONE HUNDRED NINE THOUSAND SIXTY-SIX PESOS 00/100 M.N.), towards increasing the Company’s legal reserve, which represents 5% (FIVE PERCENT) of the net income, in accordance with Article 20 of the Mexican General Law of Commercial Corporations, with the remaining balance of Ps. 8,438,072,248.00 (EIGHT BILLION FOUR HUNDRED THIRTY-EIGHT MILLION SEVENTY-TWO THOUSAND TWO HUNDRED FORTY-EIGHT PESOS 00/100 M.N.) to be allocated to the retained earnings account.
5.Presentation, discussion and submission for approval that from the retained earnings account pending application which amounts to a total of Ps. 11,685,291,653.00 (ELEVEN BILLION SIX HUNDRED EIGHTY-FIVE MILLION TWO HUNDRED NINETY-ONE THOUSAND SIX HUNDRED FIFTY-THREE PESOS 00/100 M.N.), a dividend will be declared equal to Ps. 14.84 (FOURTEEN PESOS 84/100 M.N.) pesos per share, to be paid to the holders of each share outstanding on the payment date, excluding any shares repurchased by the Company in accordance with Article 56 of the Mexican Securities Market Law; any amounts of retained earnings pending application remaining after the payment of such dividend will remain in the retained earnings account pending application. The dividend will be payable in one or more installments within 12 (twelve) months after April 13, 2023.
6.Proposal, discussion, and if applicable, approval of the cancellation of the outstanding balance, as of the date of the General Ordinary Shareholders’ Meeting, under the Share Repurchase Program approved at the General Ordinary Shareholders’ Meeting that took place on April 22, 2022, which amounts to Ps. 499,486,566.00 (FOUR HUNDRED NINETY-NINE MILLION FOUR HUNDRED EIGHTY-SIX THOUSAND FIVE HUNDRED SIXTY-SIX PESOS 00/100). Furthermore, the approval of Ps. 2,500,000,000.00 (TWO BILLION FIVE HUNDRED MILLION PESOS 00/100 M.N.) as the maximum amount to be allocated to the repurchase of the Company’s shares or credit instruments that represent such shares for the 12-month period following April 13, 2023, in accordance with Article 56, Section IV of the Mexican Securities Market Law.
7.The report regarding the designation or ratification of the four members of the Board of Directors and their respective alternates appointed by the Series BB shareholders.
8.Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by any holder or group of holders of Series B shares that owns, individually or collectively, 10% or more of the Company’s common stock.
9.Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by the Series B shareholders and certification of independence.
10.Ratification and/or designation of the Chairman of the Company’s Board of Directors, in accordance with Article 16 of the Company’s by-laws.
11.Ratification of the compensation paid to the members of the Company’s Board of Directors during the 2022 fiscal year and determination of the compensation to be paid in 2023.
12.Ratification and/or designation of the member of our Board of Directors designated by the Series B shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s bylaws.
13.Ratification and/or designation of the President of the Audit and Corporate Practices Committee.
14.The report concerning compliance with Article 29 of the Company’s bylaws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.
15.Appointment and designation of special delegates to appear before a public notary and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2023-03-02 |
股东大会：
将于2023-04-13召开股东大会
会议内容 ▼▲
- 1.Proposal to approve the cancellation of 7,024,113 (SEVEN MILLION TWENTY-FOUR THOUSAND ONE HUNDRED THIRTEEN) shares held in the Company’s treasury.
2.Perform all corporate legal formalities required, including the amendment of Article 6 of the Company’s by-laws, derived from the adoption of resolutions at this shareholders’ meeting.
3.Proposal for approval of amendment of the Company's Bylaws to add Article 29 Bis to create the Sustainability Committee. This committee will be a delegated body of the Board of Directors. Therefore, the Board of Directors will determine its duties and integration.
4.Appointment and designation of special delegates to appear before a public notary and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2021-09-29 |
股东大会：
将于2021-09-14召开股东大会
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-10 |
股东大会：
将于2021-04-27召开股东大会
会议内容 ▼▲
- 1.In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:
1.1.The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2020, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the General Law of Commercial Corporations, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in accordance with Mexican Financial Reporting Standards (“MFRS”), as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards (“IFRS”), each based on the Company’s most recent financial statements under both standards, as well as the 2020 Sustainability Report.
1.2.Board of Directors’ opinion to the Chief Executive Officer’s report.
1.3.Board of Directors’ report in accordance with Article 172, clause b, of the General Law of Commercial Corporations, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
1.4.Report on transactions and activities undertaken by the Company’s Board of Directors during the fiscal year ended December 31, 2020, pursuant to the Mexican Securities Market Law.
1.5.The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law, as well as the ratification of the actions of the various committees, and release from further obligations.
1.6.Report on the Company’s compliance with tax obligations for the fiscal year from January 1 to December 31, 2019, and an instruction to Company executives to comply with tax obligations corresponding to the fiscal year from January 1 and ended December 31, 2020, in accordance with Article 26, Section III of the Mexican Tax Code.
2.As a result of the reports in Item I above, ratification of the actions of our Board of Directors and officers and release from further obligations in the fulfillment of their duties.
3.Presentation, discussion and submission for approval of the Company’s financial statements on an unconsolidated basis in accordance with MFRS for purposes of calculating legal reserves, net income, fiscal effects related to dividend payments and capital reduction, as applicable, and approval of the financial statements of the Company and its subsidiaries on a consolidated basis in accordance with IFRS for their publication to financial markets, with respect to our operations that took place during the fiscal year from January 1 to December 31, 2020; and approval of the external auditor’s report regarding the aforementioned financial statements.
4.Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2020, reported in its unconsolidated financial statements in accordance with MFRS presented in agenda item III above, which was Ps.1,852,505,651.00 (ONE BILLION, EIGHT HUNDRED FIFTY-TWO MILLION, FIVE HUNDRED FIVE THOUSAND, SIX HUNDRED AND FIFTY-ONE PESOS 00/100 M.N.), the allocation of this amount towards increasing the Company’s retained earnings account, as long as the level of the Company’s legal reserve meets the legal requirements to which it is subject.
5.Cancellation of any amounts outstanding under the share repurchase program approved at the General Ordinary Shareholders’ Meeting that took place on July 1, 2020, and approval of Ps. 3,000,000,000.00 (THREE BILLION PESOS 00/100 M.N.) as the maximum amount to be allocated toward the repurchase of the Company’s shares or credit instruments that represent such shares for the 12-month period following April 27, 2021, in accordance with Article 56, Section IV of the Mexican Securities Market Law.
6.The report regarding the designation or ratification of the four members of the Board of Directors and their respective alternates named by the Series BB shareholders.
7.Ratification and/or designation of the person(s) that will serve as member(s) of the Company’s Board of Directors, as designated by any holder or group of holders of Series B shares that owns, individually or collectively, 10% or more of the Company’s capital stock.
8.Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by the Series B shareholders.
9.Ratification and/or designation of the Chairman of the Company’s Board of Directors, in accordance with Article 16 of the Company’s by-laws.
10.Ratification of the compensation paid to the members of the Company’s Board of Directors during the 2020 fiscal year and determination of the compensation to be paid in 2021.
11.Ratification and/or designation of the member of our Board of Directors designated by the Series B shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s bylaws.
12.Ratification and/or designation of the President of the Audit and Corporate Practices Committee.
13.The report concerning compliance with Article 29 of the Company’s by-laws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.
14.Appointment and designation of special delegates to present before a public notary and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient, in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2021-03-10 |
股东大会：
将于2021-04-27召开股东大会
会议内容 ▼▲
- 1.Proposal to approve the cancellation of 35,424,453 (THIRTY-FIVE MILLION FOUR HUNDRED TWENTY-FOUR THOUSAND, FOUR HUNDRED AND FIFTY-THREE) shares that are currently in treasury.
2.Proposal to reduce the Company’s shareholders’ equity by a total amount of up to Ps. 2,000,000,000.00 (TWO BILLION PESOS 00/100 M.N.), to be distributed among the outstanding shares at the time of payment, which will be made within the 12 (TWELVE) months following its approval.
3.Make all the legal and corporate changes, as a result of the approvals of this Shareholders’ Meeting.
4.Appointment and designation of special delegates to present before a public notary and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient, in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2020-04-15 |
股东大会：
将于2020-07-01召开股东大会
会议内容 ▼▲
- 1.In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:
a.The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2019, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in accordance with Mexican Financial Reporting Standards (“MFRS”), as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards (“IFRS”), each based on the Company’s most recent financial statements under both standards, as well as the 2019 Sustainability Report.
b.Board of directors’ comments to the Chief Executive Officer’s report.
c.Board of directors’ report in accordance with Article 172, clause b, of the Mexican General Corporations Law, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
d.Report on transactions and activities undertaken by the Company’s board of directors during the fiscal year ended December 31, 2019, pursuant to the Mexican Securities Market Law.
e.The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law, as well as ratification of the actions of the various committees, and release from further obligations.
f.Report on the Company’s compliance with tax obligations for the fiscal year from January 1 to December 31, 2018, and instruction to Company officials to comply with tax obligations corresponding to the fiscal year from January 1 and ended December 31, 2019, in accordance with Article 26, Section III of the Mexican Fiscal Code.
2.As a result of the reports in item I above, ratification of the actions by our board of directors and officers and release from further obligations in the fulfillment of their duties.
3.Presentation, discussion and submission for approval of the Company’s financial statements on an unconsolidated basis in accordance with MFRS for purposes of calculating legal reserves, net income, fiscal effects related to dividend payments and capital reduction, as applicable, and approval of the financial statements of the Company and its subsidiaries on a consolidated basis in accordance with IFRS for their publication to financial markets, with respect to operations that took place during the fiscal year from January 1 to December 31, 2019; and approval of the external auditor’s report regarding the aforementioned financial statements.
4.Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2019, reported in its unconsolidated financial statements in accordance with MFRS presented in agenda item III above, which was Ps. 5,247,808,596.00 (FIVE BILLION, TWO HUNDRED AND FORTY-SEVEN MILLION, EIGHT HUNDRED AND EIGHT THOUSAND, AND FIVE HUNDRED AND NINETY-SIX PESOS 00/100 M.N., the allocation of this amount towards increasing the Company’s legal reserves.
5.Presentation, discussion, and submission for approval of the allocation from the account for net income pending allocation, of an amount equal to Ps. 5,260,297,942.00 (FIVE BILLION, TWO HUNDRED AND SIXTY MILLION, TWO HUNDRED NINETY SEVEN THOUSAND, AND NINE HUNDRED AND FORTY-TWO PESOS 00/100 M.N.), for declaring a dividend equal to Ps. 5.14 (FIVE PESOS 14/100 M.N.S) per share, to be distributed to each share outstanding as of the payment date, excluding any shares repurchased by the Company. The dividend will be paid in the following manner:
5.1.Ps. 2.57 (TWO PESOS 57/100 M.N.) per share as of the payment date, to be distributed before August 31, 2020;
5.2.Ps. 2.57 (TWO PESOS 57/100 M.N.) per share as of the payment date, to be distributed before December 31, 2020.
6.Cancellation of any amounts outstanding under the share repurchase program approved at the General Ordinary Shareholders’ Meeting that took place on April 23, 2019 for Ps. 1,550,000,000.00 (ONE BILLION, FIVE HUNDRED AND FIFTY MILLION PESOS 00/100 M.N.) and approval of Ps. 1,550,000,000.00 (ONE BILLION, FIVE HUNDRED AND FIFTY MILLION PESOS 00/100 M.N.) as the maximum amount to be allocated toward the repurchase of the Company’s shares or credit instruments that represent such shares for the 12-month period following April 28, 2020, in accordance with Article 56, Section IV of the Mexican Securities Market Law.
7.The report regarding the designation or ratification of the four members of the board of directors and their respective alternates named by the Series BB shareholders.
8.Ratification and/or designation of the person(s) that will serve as member(s) of the Company’s board of directors, as designated by any holder or group of holders of Series B shares that owns, individually or collectively, 10% or more of the Company’s capital stock.
9.Ratification and/or designation of the persons that will serve as members of the Company’s board of directors, as designated by the Series B shareholders.
10.Ratification and/or designation of the Chairman of the Company’s board of directors, in accordance with Article 16 of the Company’s by-laws.
11.Ratification of the compensation paid to the members of the Company’s board of directors during the 2019 fiscal year and determination of the compensation to be paid in 2020.
12.Ratification and/or designation of the member of our board of directors designated by the Series B shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s bylaws.
13. Ratification and/or designation of the President of the Audit and Corporate Practices Committee.
14.The report concerning compliance with Article 29 of the Company’s bylaws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.
15.Appointment and designation of special delegates to present to a notary public the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2020-03-12 |
股东大会：
将于2020-04-28召开股东大会
会议内容 ▼▲
- 1.Proposal to reduce the Company’s shareholders’ equity by a total amount of Ps. 2,002,442,834.00 (TWO BILLION, TWO MILLION, FOUR HUNDRED AND FORTY-TWO THOUSAND, EIGHT HUNDRED AND THIRTY FOUR PESOS 00/100 M.N.) and, consequently, pay Ps. 3.81 (THREE PESOS 81/100 M.N.) per outstanding share, and if approved, amend Article 6 of the Company’s by-laws, to be payable before December 31, 2020.
2.Appointment and designation of special delegates to present to a notary public the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda point.
|
| 2019-08-21 |
除权日：
美东时间 2019-08-30 每股派息1.92美元
|
| 2019-03-11 |
股东大会：
将于2019-04-23召开股东大会
会议内容 ▼▲
- 1.In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:
a.The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2018, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in accordance with Mexican Financial Reporting Standards (“MFRS”), as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards (“IFRS”), each based on the Company’s most recent financial statements under both standards.
b.Board of directors’ comments to the Chief Executive Officer’s report.
c.Board of directors’ report in accordance with Article 172, clause b, of the Mexican General Corporations Law, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
d.Report on transactions and activities undertaken by the Company’s board of directors during the fiscal year ended December 31, 2018, pursuant to the Mexican Securities Market Law.
e.The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law, as well as ratification of the actions of the various committees, and release from further obligations.
f.Report on the Company’s compliance with tax obligations for the fiscal year from January 1 and ended December 31, 2017, and instruction to Company officials to comply with tax obligations corresponding to the fiscal year from January 1 and ended December 31, 2018, in accordance with Article 26, Section III of the Mexican Fiscal Code.
2.As a result of the reports in item I above, ratification of the actions by our board of directors and officers and release from further obligations in the fulfillment of their duties.
3.Presentation, discussion and submission for approval of the Company’s financial statements on an unconsolidated basis in accordance with MFRS for purposes of calculating legal reserves, net income, fiscal effects related to dividend payments and capital reduction, as applicable, and approval of the financial statements of the Company and its subsidiaries on a consolidated basis in accordance with IFRS for their publication to financial markets, with respect to operations that took place during the fiscal year from January 1 and ended December 31, 2018; and approval of the external auditor’s report regarding the aforementioned financial statements.
4.Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2018, reported in its unconsolidated financial statements in accordance with MFRS presented in agenda item III above, which was Ps. 4,936,818,189.00 (FOUR BILLION, NINE HUNDRED AND THIRTY SIX MILLION, EIGHT HUNDRED AND EIGHTEEN THOUSAND, AND ONE HUNDRED AND EIGHTY-NINE PESOS 00/100 M.N., the allocation of 5% (FIVE PERCENT) of this amount, or Ps. 246,840,909.00 (TWO HUNDRED AND FORTY-SIX MILLION, EIGHT HUNDRED FORTY THOUSAND AND NINE HUNDRED AND NINE PESOS 00/100 M.N.), towards increasing the Company’s legal reserves, with the remaining balance of Ps. 4,689,977,280.00 (FOUR BILLION, SIX HUNDRED AND EIGHTY-NINE MILLION, NINE HUNDRED SEVENTY-SEVEN THOUSAND AND TWO HUNDRED AND EIGHTY PESOS 00/100 M.N. to be allocated to the account for net income pending allocation.
5.Presentation, discussion, and submission for approval of the allocation from the account for net income pending allocation, of an amount equal to Ps. 4,737,835,452.00 (FOUR BILLION, SEVEN HUNDRED AND THIRTY-SEVEN MILLION, EIGHT HUNDRED THIRTY-FIVE THOUSAND, AND FOUR HUNDRED AND FIFTY-TWO PESOS 00/100 M.N.), for declaring a dividend equal to Ps. 8.42 (EIGHT PESOS AND FORTY TWO CENTS) per share, to be distributed to each share outstanding as of the payment date, excluding any shares repurchased by the Company as of each payment date in accordance with Article 56 of the Mexican Securities Market Law; any amounts of net income pending allocation remaining after the payment of such dividend will remain in the account for net income pending allocation. The dividend will be paid in the following manner:
i)Ps. 4.21 (FOUR PESOS 21/100 M.N.) per share as of the payment date, to be distributed before August 31, 2019;
ii)Ps. 4.21 (FOUR PESOS 21/100 M.N.) per share as of the payment date, to be distributed before December 31, 2019.
6.Cancellation of any amounts outstanding under the share repurchase program approved at the Annual General Ordinary Shareholders’ Meeting that took place on April 25, 2018 for Ps. 1,250,000,000.00 (ONE BILLION, TWO HUNDRED AND FIFTY MILLION PESOS 00/100 M.N.) and approval of Ps. 1,550,000,000.00 (ONE BILLION, FIVE HUNDRED AND FIFTY MILLION PESOS 00/100 M.N.) as the maximum amount to be allocated toward the repurchase of the Company’s shares or credit instruments that represent such shares for the 12-month period following April 23, 2019, in accordance with Article 56, Section IV of the Mexican Securities Market Law.
7.The report regarding the designation or ratification of the four members of the board of directors and their respective alternates named by the Series BB shareholders.
8.Ratification and/or designation of the person(s) that will serve as member(s) of the Company’s board of directors, as designated by any holder or group of holders of Series B shares that owns, individually or collectively, 10% or more of the Company’s capital stock.
9.Ratification and/or designation of the persons that will serve as members of the Company’s board of directors, as designated by the Series B shareholders.
10.Ratification and/or designation of the Chairman of the Company’s board of directors, in accordance with Article 16 of the Company’s by-laws.
11.Ratification of the compensation paid to the members of the Company’s board of directors during the 2018 fiscal year and determination of the compensation to be paid in 2019.
12.Ratification and/or designation of the member of our board of directors designated by the Series B shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s bylaws.
13.Ratification and/or designation of the President of the Audit and Corporate Practices Committee.
14.The report concerning compliance with Article 29 of the Company’s bylaws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.
15.Appointment and designation of special delegates to present to a notary public the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2018-11-13 |
除权日：
美东时间 2018-11-21 每股派息1.69美元
|
| 2018-08-10 |
除权日：
美东时间 2018-08-17 每股派息2.00美元
|
| 2018-03-12 |
股东大会：
将于2018-04-25召开股东大会
会议内容 ▼▲
- 1.In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:
a.The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2017, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in accordance with Mexican Financial Reporting Standards (“MFRS”), as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards (“IFRS”), each based on the Company’s most recent financial statements under both standards.
b.Our board of directors’ comments to the Chief Executive Officer’s report.
c.Our board of directors’ report in accordance with Article 172, clause b, of the Mexican General Corporations Law, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
d.Report on transactions and activities undertaken by our board of directors during the fiscal year ended December 31, 2017, pursuant to the Mexican Securities Market Law.
e.The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law, as well as ratification of the actions of the various committees, and release from further obligations.
f.Report on the Company’s compliance with tax obligations for the fiscal year ended December 31, 2016, and instruction to Company officials to comply with tax obligations corresponding to the fiscal year ended December 31, 2017, in accordance with Article 26, Section III of the Mexican Fiscal Code.
2.As a result of the reports in item I above, ratification of the actions by our board of directors and officer and release from further obligations in the fulfillment of their duties.
3.Presentation, discussion and submission for approval of the Company’s financial statements on an unconsolidated basis in accordance with MFRS for purposes of calculating legal reserves, net income, fiscal effects related to dividend payments and capital reduction, as applicable, and approval of the financial statements of the Company and its subsidiaries on a consolidated basis in accordance with IFRS for their publication to financial markets, with respect to operations during the fiscal year ended December 31, 2017 fiscal period; and approval of the external auditor’s report regarding the aforementioned financial statements.
4.Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2017, reported in its unconsolidated financial statements in accordance with MFRS presented in agenda item III above, which was Ps. 4,533,604,331.00 (FOUR BILLION, FIVE HUNDRED AND THIRTY THREE MILLION, SIX HUNDRED AND FOUR THOUSAND, AND THREE HUNDRED AND THIRTY ONE PESOS 00/100 M.N., the allocation of 5% (FIVE PERCENT) of this amount, or Ps. 226,680,217.00 (TWO HUNDRED AND TWENTY-SIX MILLION, SIX HUNDRED AND EIGHTY THOUSAND AND TWO HUNDRED AND SEVENTEEN PESOS 00/100 M.N.), towards increasing the Company’s legal reserves, with the remaining balance of Ps. 4,306,924,114.00 (FOUR BILLION, THREE HUNDRED AND SIX MILLION, NINE HUNDRED AND TWENTY-FOUR THOUSAND, AND ONE HUNDRED AND FOURTEEN PESOS 00/100 M.N. to be allocated to the account for net income pending allocation.
5.Presentation, discussion, and submission for approval of the allocation from the account for net income pending allocation, of an amount equal to Ps. 4,307,743,840.00 (FOUR BILLION, THREE HUNDRED AND SEVEN MILLION, SEVENHUNDRED AND FORTY-THREE THOUSAND, AND EIGHT HUNDRED AND FORTY PESOS 00/100 M.N.), for declaring a dividend equal to Ps. 7.62 (SEVEN PESOS AND SIXTY TWO CENTS) per share, to be distributed to each share outstanding as of the payment date, excluding any shares repurchased by the Company as of each payment date in accordance with Article 56 of the Mexican Securities Market Law; any amounts of net income pending allocation remaining after the payment of such dividend will remain in the account for net income pending allocation.
The dividend will be paid in the following manner:
i)Ps. 3.81 (THREE PESOS 81/100 M.N.) per share as of the payment date, to be distributed before August 31, 2018;
ii)Ps. 3.81 (THREE PESO 81/100 M.N.) per share as of the payment date, to be distributed before December 31, 2018.
6.Cancellation of any amounts outstanding under the share repurchase program approved at the Annual General Ordinary Shareholders’ Meeting that took place on April 25, 2017 for Ps. 995,000,000.00 (NINE HUNDRED AND NINETY FIVE MILLION PESOS 00/100 M.N.) and approval of Ps. 1,250,000,000.00 (ONE BILLION, TWO HUNDRED AND FIFTY MILLION PESOS 00/100 M.N.) as the maximum amount to be allocated toward the repurchase of the Company’s shares or credit instruments that represent such shares for the 12-month period following April 25, 2018, in accordance with Article 56, Section IV of the Mexican Securities Market Law.
7.The report regarding the designation or ratification of the four members of our board of directors and their respective alternates named by the Series BB shareholders.
8.Ratification and/or designation of the person(s) that will serve as member(s) of the Company’s board of directors, as designated by any holder or group of holders of Series B shares that owns, individually or collectively, 10% or more of the Company’s capital stock.
9.Ratification and/or designation of the persons that will serve as members of the Company’s board of directors, as designated by the Series B shareholders.
10.Ratification and/or designation of the Chairman of the Company’s board of directors, in accordance with Article 16 of the Company’s bylaws.
11.Ratification of the compensation paid to the members of the Company’s board of directors during the 2017 fiscal year and determination of the compensation to be paid in 2018.
12.Ratification and/or designation of the member of our board of directors designated by the Series B shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s bylaws.
13.Ratification and/or designation of the President of the Audit and Corporate Practices Committee
14.The report concerning compliance with Article 29 of the Company’s bylaws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.
15.Appointment and designation of special delegates to present to a notary public the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.
|
| 2018-03-12 |
股东大会：
将于2018-04-25召开股东大会
会议内容 ▼▲
- 1.Proposal to reduce the Company’s shareholders’ equity by a total amount of Ps. 1,250,869,801.86 (ONE BILLION, TWO HUNDRED AND FIFTY MILLION, EIGHT HUNDRED AND SIXTY NINE THOUSAND, EIGHT HUNDRED AND ONE PESOS 86/100 M.N.) and, consequently, pay Ps. 2.38 (TWO PESOS AND THIRTY EIGHT CENTS) per outstanding share, and if approved, amend Article 6 of the Company’s bylaws.
2.Appointment and designation of special delegates to present to a notary public the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda points.
|
| 2017-08-16 |
股东大会：
将于2017-04-25召开股东大会
|
| 2017-08-03 |
除权日：
美东时间 2017-08-10 每股派息1.60美元
|
| 2016-11-09 |
除权日：
美东时间 2016-11-15 每股派息0.87美元
|
| 2016-08-11 |
除权日：
美东时间 2016-08-22 每股派息1.23美元
|
| 2016-05-11 |
除权日：
美东时间 2016-05-12 每股派息1.85美元
|
| 2016-03-03 |
股东大会：
将于2016-04-26召开股东大会
会议内容 ▼▲
- 1. The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2015, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in accordance with Mexican Financial Reporting Standards (“MFRS”), as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards (“IFRS”), each based on the Company’s most recent financial statements under both standards.
2. Our board of directors’ comments to the Chief Executive Officer’s report.
3. Our board of directors’ report in accordance with Article 172, clause b, of the Mexican General Corporations Law, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
|
| 2015-10-01 |
除权日：
美东时间 2015-11-05 每股派息0.90美元
|
| 2015-07-28 |
除权日：
美东时间 2015-08-20 每股派息1.06美元
|
| 2015-04-28 |
除权日：
美东时间 2015-05-14 每股派息1.77美元
|
| 2015-03-06 |
股东大会：
将于2015-04-21召开股东大会
会议内容 ▼▲
- Annual general meeting：
I.In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:
a)The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2014, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an individual basis in accordance with Mexican Generally Accepted Accounting Principles (“Mexican GAAP”) as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards, based on the Company’s most recent financial statements under both norms.
b)The Board of Directors’ comments to the Chief Executive Officer’s report.
c)The Board of Directors’ report in accordance with Article 172, clause b, of the Mexican General Corporations Law, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
d)The report on operations and activities undertaken by the Board of Directors during the fiscal year ended December 31, 2014, pursuant to the Mexican Securities Market Law.
e)The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law. Ratification of the actions of the various committees, and release from further obligations.
f) The report on the Company’s compliance with tax obligations for the fiscal year of January 1 to December 31, 2013. Instruction to Company officials to comply with tax obligations corresponding to the fiscal year of January 1 to December 31, 2014, in accordance with Article 26, Section III of the Mexican Fiscal Code.
g)Ratification of the decisions taken by the Board of Directors, and release from further obligations in the fulfillment of its duties.
II.Presentation, discussion, and submission for approval of the Company’s financial statements on an individual basis in accordance with Mexican GAAP for purposes of calculating the legal reserves, net income, fiscal effects related to dividend payments, and the capital reduction, as applicable, and approval of the financial statements of the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards for their publication to financial markets, with respect to operations during the January 1 to December 31, 2014 fiscal period; and approval of the external auditor’s report regarding the aforementioned financial statements.
III.Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2014, reported in the individual Financial Statements audited in accordance with Mexican GAAP presented in point II of the Agenda, above, which was Ps. 2,105,041,199.00 (TWO BILLION, ONE HUNDRED AND FIVE MILLION, FOURTY ONE THOUSAND, ONE HUNDRED AND NINETY NINE PESOS), the allocation of 5% (FIVE PERCENT) of this amount, or Ps. 105,252,059.95 (ONE HUNDRED AND FIVE MILLION, TWO HUNDRED FIFTY TWO THOUSAND, FIFTY NINE PESOS AND NINETY FIVE CENTS), towards increasing the Company’s legal reserves, with the remaining balance of Ps. 1,999,789,139.05 (ONE BILLION, NINE HUNDRED NINETY NINE MILLION, SEVEN HUNDRED EIGHTY NINE THOUSAND, ONE HUNDRED AND THIRTY NINE PESOS AND FIVE CENTS), to be allocated to the account for net income pending allocation.
IV.Presentation, discussion, and submission for approval of the allocation from the account for net income pending allocation, of an amount equal to Ps. 2,198,682,664.05 (TWO BILLION, ONE HUNDRED NINETY EIGHT MILLION, SIX HUNDRED EIGHTY TWO THOUSAND, SIX HUNDRED AND SIXTY FOUR PESOS AND FIVE CENTS), for declaring a dividend equal to Ps. 3.32 per share (THREE PESOS AND THIRTY TWO CENTS), to be distributed equally among each share outstanding as of the payment date, excluding the shares repurchased by the Company as of each payment date in accordance with Article 56 of the Mexican Securities Market Law; any amounts of net income pending allocation remaining after the payment of such dividend will remain in the account for net income pending allocation.
The dividend will be paid in the following manner:
i)Ps. 1.82 per outstanding share as of the payment date (ONE PESO AND EIGHTY TWO CENTS) before August 31, 2015;
ii)Ps. 1.50 per outstanding share as of the payment date (ONE PESO AND FIFTY CENTS) before December 31, 2015.
V.Cancellation of any amounts outstanding under the share repurchase program approved at the Ordinary Shareholders’ Meeting that took place on April 23, 2014 for Ps. 400,000,00.00 (FOUR HUNDRED MILLION PESOS) and approval of Ps. 850,000,000.00 (EIGHT HUNDRED AND FIFTY MILLION PESOS) as the maximum amount to be allocated toward the repurchase of the Company’s shares or credit instruments that represent those shares for the 12-month period after April 21, 2015, in accordance with Article 56, Section IV of the Mexican Securities Market Law.
VI.The report regarding the designation or ratification of the four members of the Board of Directors and their respective alternates named by the Series “BB” shareholders.
VII.Ratification and/or designation of the person(s) that will serve as member(s) of the Company’s Board of Directors, as designated by any holder or group of holders of Series “B” shares that own, individually or collectively, 10% or more of the Company’s capital stock.
VIII.Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by the Series “B” shareholders, and resolutions in respect thereof.
IX.Ratification of the Company’s Chairman of the Board of Directors, in accordance with Article 16 of the Company’s by-laws.
X.Ratification of the compensation paid to the members of the Company’s Board of Directors during the 2014 fiscal year and determination of the compensation to be paid in 2015.
XI.Ratification and/or designation of the member of the Board of Directors designated by the Series “B” shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s by-laws.
XII.Ratification and/or designation of the President of the Audit and Corporate Practices Committee.
XIII.The report concerning compliance with Article 29 of the Company’s by-laws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.
XIV.Appointment and designation of Special Delegates to present to a Notary Public the resolutions adopted at this Meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding Agenda points.
Special meeting：
I.Proposal to reduce the Company’s shareholder equity by Ps. 2.68 per outstanding share (TWO PESOS AND SIXTY EIGHT CENTS) for a total amount of Ps. 1,408,542,465.96 (ONE BILLION FOUR HUNDRED AND EIGHT MILLION FIVE HUNDRED FORTY TWO THOUSAND FOUR HUNDRED SIXTY FIVE PESOS AND NINETY SIX CENTS), and amending Article 6 of the Company’s by-laws.
II.Appointment and designation of Special Delegates to present to a Notary Public the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding Agenda points.
|
| 2014-06-27 |
除权日：
美东时间 2014-07-02 每股派息0.58美元
|
| 2014-05-20 |
除权日：
美东时间 2014-05-27 每股派息1.75美元
|
| 2014-05-02 |
除权日：
美东时间 2014-05-08 每股派息2.21美元
|
| 2014-03-03 |
股东大会：
将于2014-04-23召开股东大会
会议内容 ▼▲
- Annual general meeting：
1. In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:
a)The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2013, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an individual basis in accordance with Mexican Generally Accepted Accounting Principles (“Mexican GAAP”) as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards, based on the Company’s most recent financial statements under both norms.
b)The Board of Directors’ comments to the Chief Executive Officer’s report.
c)The Board of Directors’ report in accordance with Article 172, clause b, of the Mexican General Corporations Law, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.
d)The report on operations and activities in which the Board of Directors intervened during the fiscal year ended December 31, 2013, pursuant to the Mexican Securities Market Law.
e)The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law. Ratification of the actions of the various committees, and release from further obligations.
f)The report on the Company’s compliance with tax obligations for the fiscal year of January 1 to December 31, 2012. Instruction to Company officials to comply with tax obligations corresponding to the fiscal year of January 1 to December 31, 2013, in accordance with Article 26, Section III of the Mexican Fiscal Code.
g)Ratification of the decisions taken by the Board of Directors, including the designation of provisional directors, and release from further obligations in the fulfillment of its duties. In addition, ratification of the actions of the President and Officers of the Company, and release from further obligations.
2. Presentation, discussion, and submission for approval of the Company’s financial statements on an individual basis in accordance with Mexican GAAP for purposes of calculating the legal reserves, net income, fiscal effects related to dividend payments, and the capital reduction, as applicable, and approval of the financial statements of the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards for their publication to financial markets, with respect to operations during the January 1 to December 31, 2013 fiscal period; and approval of the external auditor’s report regarding the aforementioned financial statements.
3. Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2013, reported in the individual Financial Statements audited in accordance with Mexican GAAP presented in point II of the Agenda, above, which was Ps. 1,991,540,839.00 (ONE BILLION, NINE HUNDRED NINETY ONE MILLION, FIVE HUNDRED FOURTY THOUSAND, EIGHT HUNDRED AND THIRTY NINE PESOS), the allocation of 5% (FIVE PERCENT) of this amount, or Ps. 99,577,042.00 (NINETY NINE MILLION, FIVE HUNDRED SEVENTY SEVEN THOUSAND, FORTY TWO PESOS), towards increasing the Company’s legal reserves, with the remaining balance of Ps. 1,891,963,797.00 (ONE BILLION, EIGHT HUNDRED NINETY ONE MILLION, NINE HUNDRED SIXTY THREE THOUSAND, SEVEN HUNDRED AND NINETY SEVEN PESOS), to be allocated to the account for net income pending allocation.
4. Presentation, discussion, and submission for approval of the allocation from the account for net income pending allocation, of an amount equal to Ps. 1,894,965,784.00 (ONE BILLION, EIGHT HUNDRED NINETY FOUR MILLION, NINE HUNDRED SIXTY FIVE THOUSAND, SEVEN HUNDRED AND EIGHTY FOUR PESOS), for declaring a dividend in the amount of Ps. 1,590,000,000.00 (ONE BILLION, FIVE HUNDRED NINETY MILLION PESOS), to be distributed equally among each share outstanding as of the payment date, excluding the shares repurchased by the Company as of each payment date in accordance with Article 56 of the Mexican Securities Market Law; any amounts of net income pending allocation remaining after the payment of such dividend will remain in the account for net income pending allocation.
5. Cancelation of any amounts outstanding under the share repurchase program approved at the Ordinary Shareholders’ Meeting that took place on April 16, 2013 for Ps. 280,728,734.00 (TWO HUNDRED EIGHTY MILLION, SEVEN HUNDRED TWENTY EIGHT THOUSAND AND SEVEN HUNDRED THIRTY FOUR PESOS) and approval of Ps. 400,000,000.00 (FOUR HUNDRED MILLION PESOS) as the maximum amount to be allocated toward the repurchase of the Company’s shares or credit instruments that represent those shares for the 12-month period after April 23, 2014, in accordance with Article 56, Section IV of the Mexican Securities Market Law.
6. The report regarding the designation or ratification of the four members of the Board of Directors and their respective alternates named by the Series “BB” shareholders.
7. Ratification and/or designation of the person(s) that will serve as member(s) of the Company’s Board of Directors, as designated by any holder or group of holders of Series “B” shares that own, individually or collectively, 10% or more of the Company’s capital stock.
8. Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by the Series “B” shareholders, and resolutions in respect thereof.
9. Ratification of the Company’s Chairman of the Board of Directors, in accordance with Article 16 of the Company’s by-laws.
10. Ratification of the compensation paid to the members of the Company’s Board of Directors during the 2013 fiscal year and determination of the compensation to be paid in 2014.
11. Ratification and/or designation of the member of the Board of Directors designated by the Series “B” shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s by-laws.
12. Ratification and/or designation of the President of the Audit and Corporate Practices Committee.
13. The report concerning compliance with Article 29 of the Company’s by-laws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.
14. Appointment and designation of Special Delegates to present to a Notary Public the resolutions adopted at this Meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding Agenda points.
Special meeting：
1. Proposal to reduce the Company’s shareholder equity by up to Ps. 1,510,000,000.00 (ONE BILLION FIVE HUNDRED AND TEN MILLION PESOS), and amending Article 6 of the Company’s by-laws.
2. Change in the Company’s legal address, and amending Articles 3 and 52 of the Company’s by-laws.
3. Appointment and designation of Special Delegates to present to a Notary Public the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding Agenda points.
|
| 2013-11-21 |
除权日：
美东时间 2013-11-27 每股派息0.44美元
|
| 2013-04-19 |
除权日：
美东时间 2013-04-25 每股派息1.40美元
|
| 2012-10-23 |
除权日：
美东时间 2012-10-31 每股派息0.40美元
|
| 2012-09-27 |
除权日：
美东时间 2012-10-03 每股派息1.28美元
|
| 2012-05-24 |
除权日：
美东时间 2012-05-31 每股派息1.11美元
|
| 2011-11-19 |
除权日：
美东时间 2011-11-23 每股派息0.35美元
|
| 2011-05-19 |
除权日：
美东时间 2011-05-25 每股派息1.24美元
|
| 2010-08-03 |
除权日：
美东时间 2010-08-16 每股派息0.34美元
|
| 2010-06-08 |
除权日：
美东时间 2010-11-24 每股派息0.34美元
|
| 2010-06-05 |
除权日：
美东时间 2010-06-10 每股派息1.04美元
|